logo
How AI can finally fix prior authorization

How AI can finally fix prior authorization

Fast Companya day ago
If you've ever been a patient waiting—days, sometimes more than a week—for treatment approval, or a clinician stuck chasing it, you know what prior authorization feels like. Patients sit in limbo, anxiety growing as care stalls. Nurses and physicians trade hours of patient time for phone calls, faxes, and glitchy portals. Everyone waits, some in pain, while the people on both sides of the system lose faith in it a little more each day.
This isn't a minor inconvenience. According to the American Medical Association's (AMA) 2024 Prior Authorization Physician Survey, 93% of physicians report that prior authorization delays access to care, and 94% say it negatively affects patient outcomes. Physicians handle an average of nearly 40 requests each week, spending 13 hours of their time on the process. Nearly 9 out of 10 share that it's a contributing factor to burnout.
We've been down this road for many years. In 2018, health insurer and provider groups signed a consensus statement promising significant improvement of prior authorization. In 2023, the AMA reported that two major insurers pledged to reduce the number of services needing prior authorization.
The promises added up—so why hasn't the burden eased?
Last month, AHIP (a national trade association representing the health insurance industry) and major payers rolled out six reforms standardizing electronic submissions, speeding decisions, improving transparency, and preserving continuity of care when members switch plans. More than 50 leading health plans, encompassing 257 million Americans, signed on to be a part of this reform with all commitments delivered by 2027. That's important. But for someone awaiting chemotherapy or a nurse on the ward, 2027 feels like forever away.
No need to wait
Real reform doesn't need to wait. Here's what's already happening inside health plans that have embraced agent‑based AI systems—technology is being put in place that's designed not just to speed up forms but to fundamentally change how prior authorization and other core operations get done. These systems don't replace people. They work alongside nurses, case managers, and administrators, handling the repetitive, document-heavy work so humans can focus on clinical decisions and patient care.
Tangible results
This AI is just beginning to be adopted by plans; the transformation is measurable:
Turnaround times are slashed by more than 50%.
76% of authorizations are handled automatically.
Eighteen minutes are saved per prior authorization request, which for an average-sized health plan unlocks tens of thousands of hours each month, that enables clinical care teams to shift from administrative work to greater focus on patients.
AI can handle the tedious parts of the process—sorting through PDFs, faxes, and clinical notes—in seconds instead of hours, while keeping nurses and physicians involved for the decisions that require human judgment.
Paradigm shift
This isn't just a tweak to the old process—it's a shift that allows entire operations teams to work differently. Patients get quicker answers and fewer anxious phone calls. Providers get back more time to spend helping patients. For the people working behind the scenes, it means moving past the repetitive paperwork grind—hours spent sorting through forms, faxes, and files—and focusing on work that actually supports better care.
AHIP's own language makes the case: these reforms are meant to provide faster access to evidence-based care, simplify workflows for providers, and preserve care continuity when people switch insurers. That should be the minimum standard—not a distant promise.
Health plans need to act now—scaling existing AI deployments and embracing process redesign—so they can deliver three concrete outcomes today:
Patients can start the treatments they need sooner, without the constant back‑and‑forth or long waits for approval.
Doctors and nurses get back valuable time, so they can spend more of their day with patients instead of buried in forms and phone calls.
People can keep their care moving, even if they switch insurance plans mid‑treatment, without having to start the approval process all over again.
Within reach
Health plans don't need to wait for 2027. The technology exists today to deliver meaningful prior authorization reform. And let's be honest: another round of press releases won't change outcomes. But scaling the results and impact that AI is delivering to prior authorization today—that's reform in motion. And it's within reach.
For patients trapped in limbo and clinicians stretched thinner every day, reform can't arrive soon enough. The question isn't whether we can make prior authorization faster, simpler, and less needed. It's when health plans will act—for the sake of all those involved in our health system, we must choose urgency.
The early-rate deadline for Fast Company's Most Innovative Companies Awards is Friday, September 5, at 11:59 p.m. PT. Apply today.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

Yahoo

time11 minutes ago

  • Yahoo

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

HealthPartners launches simple, copay-only health plan
HealthPartners launches simple, copay-only health plan

Yahoo

time11 minutes ago

  • Yahoo

HealthPartners launches simple, copay-only health plan

Simplica NextGen Copay plan provides costs up front, lets members compare providers, and can save employers up to 15% compared to other plan options. BLOOMINGTON, Minn., August 14, 2025--(BUSINESS WIRE)--HealthPartners is launching a variable copay benefit plan that aims to provide unparalleled transparency of cost and coverage to members. HealthPartners Simplica NextGen Copay health plan has no deductible or coinsurance for in-network care, and members see what they'll pay up front before scheduling. Copay amounts for specific services at each hospital or clinic vary based on the quality and affordability of the care delivered. A key feature of the plan is the personalized digital experience fully integrated within a member's HealthPartners account. Using HealthPartners' Find Care tool, members can search by condition, provider or service; compare care options; and see their exact copay before scheduling. Members pay less when they choose care with better outcomes. "We developed Simplica in response to the growing demand for more predictable benefits," says Andrea Walsh, HealthPartners president and CEO. "This plan gives members the cost clarity and ease they expect from their health plan and guides them in making informed decisions about where to get the care they need." For example, the copay for an office visit will range from $20 to $150 depending upon the plan option, care site and service. Most same day labs and x-rays are bundled into the copay – helping reduce unexpected costs. Services that may require a separate copay are also visible through the Find Care digital experience. In addition, many virtual care options are covered at a $0 copay. The plan will launch Jan. 1, 2026, and is initially available to large-group, self-insured employers in the Twin Cities metro and surrounding counties. Simplica can save companies up to 15% in claim costs and that translates into savings for employees. "Unlike third-party platforms or standalone applications, Simplica delivers one seamless experience that makes it easier for members and employers to understand and manage costs," says Moe Suleiman, HealthPartners senior vice president of health solutions. "This plan ties copays to provider value, guides members in real time, and delivers the digital-first convenience today's workforce expects." For more information, visit the Simplica NextGen Copay website. About HealthPartners HealthPartners is a nonprofit organization with a mission of improving health and well-being in partnership with its members, patients and community. An integrated system of care and coverage since its founding in 1957, HealthPartners operates hospitals and clinics, health plans, and a research and education institute. The Minneapolis-based organization serves more than 1.3 million patients in Minnesota and Wisconsin and 1.7 million medical and dental health plan members nationwide. For more information, visit View source version on Contacts Amanda

Medscape 2050: Renee Salas
Medscape 2050: Renee Salas

Medscape

time13 minutes ago

  • Medscape

Medscape 2050: Renee Salas

Medscape 2050: The Future of Medicine 'Indirect impacts of climate change on healthcare delivery are broad and insidious,' says Renee Salas. MD, an emergency room physician at Mass General whose work has focused on the climate crisis. 'They can range from supply chain disruptions to power outages to more patients displaced from their home healthcare system.' As the lead author of the Lancet Countdown on Health and Climate Change U.S. Brief since 2018, founder of its Working Group, and co-director for the Climate Crisis and Clinical Practice Initiative in partnership with The New England Journal of Medicine, Salas has a breadth of knowledge on how climate change is impacting healthcare worldwide. But she has also seen the damage in her own practice. When Hurricane Helene hit the southeastern US, it caused IV saline shortages, forcing Salas to hand out Gatorade to patients in need of fluids. By 2050, the global temperature is forecasted to be 2 °C above preindustrial levels. 'Extreme heat events that would only occur twice a century without climate change are predicted to be nearly 14 times more likely to occur with increased intensity,' Salas warns. The 2021 Pacific Northwest heat wave in British Columbia caused over 900 excess deaths as emergency rooms were not used to accommodating the heat. The hotter world will also bring more wildfires, droughts, destructive hurricanes, and floods. 'Right now,' says Salas, 'healthcare is reactive and unprepared.' Health outcomes will be increasingly impacted by what happens outside the doors of a hospital or a clinic room. And Salas urges healthcare systems to embrace preventative models, including more flexible and nimbler care delivery. We need 'individual heat wave plans, income-based energy assistance, protective cooling, home weatherization, and even home biosensors for patients who are at high risk.' Facing this issue can be a unifier, Salas believes. 'Healthcare can be that bridge that works across silos for an integrated health centered response, embedding cross sector collaboration with entities like the energy sector or urban planning to create a healthcare system in 2050 that is ready for what climate change brings.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store